In addition, in vivo and clinical studies are a focus of further investigations to validate the potential application of HHT and HT in treating interferonopathy and autoimmune diseases caused by dysregulation of the cGAS-STING pathway. This evidence concerns the gene STING1 and autoimmune disease.